Conway Charles
Insider CIK 1704256 · BHVN Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 7,500 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 3,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 775 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 25,225 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 2,398 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 27,602 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 25,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 6,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 41,432 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 5,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 54,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 61,916 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 3,084 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 295 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer deriv | 2022-10-03 | 2022-10-03 | 11,500 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | D To issuer | 2022-10-03 | 2022-10-03 | 22,362 | $148.50 | $3.32M | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2022-01-07 | 2022-01-07 | 23,000 | — | $0 | 23,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2022-01-07 | 2022-01-07 | 11,500 | — | $0 | 11,500 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2022-01-06 | 2022-01-07 | 3,750 | — | $0 | 7,500 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2022-01-06 | 2022-01-07 | 1,800 | $123.86 | $222.9K | 22,135 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2022-01-06 | 2022-01-07 | 3,750 | — | $0 | 23,935 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2021-11-25 | 2021-11-26 | 3,000 | — | $0 | 3,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2021-11-25 | 2021-11-26 | 3,000 | — | $0 | 19,897 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2021-11-23 | 2021-11-26 | 10,000 | — | $0 | 0 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2021-11-23 | 2021-11-26 | 885 | — | $0 | 41,727 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2021-11-23 | 2021-11-26 | 10,000 | $37.54 | $375.4K | 16,012 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2021-11-23 | 2021-11-26 | 885 | $20.79 | $18.4K | 16,897 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2021-01-06 | 2021-01-08 | 3,750 | — | $0 | 11,250 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2021-01-06 | 2021-01-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2021-01-06 | 2021-01-08 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2021-01-06 | 2021-01-08 | 1,747 | $83.38 | $145.7K | 10,012 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2021-01-06 | 2021-01-08 | 3,750 | — | $0 | 11,759 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2020-11-25 | 2020-11-27 | 3,000 | — | $0 | 6,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2020-11-25 | 2020-11-27 | 1,361 | $90.14 | $122.7K | 7,278 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2020-11-25 | 2020-11-27 | 3,000 | — | $0 | 8,639 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise deriv | 2019-12-18 | 2019-12-20 | 3,000 | — | $0 | 9,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | F Tax w/h | 2019-12-18 | 2019-12-20 | 1,361 | $52.13 | $70.9K | 5,639 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | M Exercise | 2019-12-18 | 2019-12-20 | 3,000 | — | $0 | 7,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2019-11-25 | 2019-11-27 | 12,000 | — | $0 | 12,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2019-11-25 | 2019-11-27 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2019-06-27 | 2019-07-01 | 6,000 | — | $0 | 6,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2017-12-07 | 2021-11-26 | 42,612 | — | $0 | 42,612 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2017-12-07 | 2017-12-11 | 32,612 | — | $0 | 32,612 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | A Award deriv | 2017-09-05 | 2017-09-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BHVN Biohaven Pharmaceutical Ho | P Buy | 2017-05-09 | 2017-05-11 | 4,000 | $17.00 | $68.0K | 4,000 | SEC↗ |